申请人:GLAXO GROUP LTD
公开号:WO2004072069A1
公开(公告)日:2004-08-26
Compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein P, W, X, Y, R2, R3, r and s are as defined in the specification, processes for preparing such compounds, pharmaceutical compositions comprising such compounds and their use in therapy.
式(I)的化合物或其药用可接受的盐或溶剂,其中P、W、X、Y、R2、R3、r和s如规范中定义,制备这类化合物的方法,包含这类化合物的药物组合物及其在治疗中的应用。